GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Harrow HROW · USD

Health Care · US listing · 🇺🇸 United States

Compare

27.47

+2.16%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$272.3m

FY2016FY2025

Net income

−$5.1m

FY2016FY2025

Free cash flow

$42.8m

FY2016FY2025

Shareholders' equity

$52.4m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$272.3m$199.6m$130.2m$88.6m$72.5m$48.9m$51.2m$41.4m$26.8m$19.9m
Gross profit$204.4m$150.4m$90.6m$63.2m$54.3m$34.4m$34.4m$24.9m$13.3m$10.1m
Research and development$12.8m$12.2m$6.7m$3.0m$11.1m$2.4m$2.1m$825,000$413,000$739,000
Operating income$38.6m$8.8m$431,000$1.9m$1.6m$385,000−$4.8m−$5.2m−$12.2m−$16.4m
Net income−$5.1m−$17.5m−$24.4m−$14.1m−$18.0m−$3.4m$168,000$14.6m−$12.0m−$19.1m
Diluted earnings per share-0.14-0.49-0.69-0.48-0.66-0.130.010.60-0.57-1.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$399.5m$389.0m$311.8m$157.0m$98.3m$57.5m$59.1m$49.5m$23.9m$27.2m
Cash and short-term investments$72.9m$47.2m$82.8m$96.3m$50.7m$32.7m$29.9m$28.1m$4.0m$8.9m
Total liabilities$347.4m$319.7m$241.8m$130.1m$87.4m$30.6m$31.7m$24.7m$21.3m$20.8m
Debt$243.2m$219.5m$183.2m$104.2m$71.7m$16.3m$14.0m$15.2m$15.3m$13.7m
Shareholders' equity$52.4m$69.7m$70.4m$26.9m$11.3m$27.2m$27.7m$24.8m$2.6m$6.4m
Shares outstanding37m36m35m29m27m26m26m24m21m19m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$43.9m−$22.2m$3.8m$1.7m$5.1m−$1.1m$950,000$687,000−$8.8m−$11.2m
Capital spending−$1.1m−$38.7m−$152.6m−$7.8m−$28.5m−$994,000−$1.8m−$2.2m−$1.1m−$7.1m
Free cash flow$42.8m−$60.9m−$148.7m−$6.1m−$23.4m−$2.1m−$887,000−$1.5m−$9.9m−$18.4m
Dividends paid———−$876,000−$127,000−$58,000−$127,000−$127,000—−$4.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$70.7m$44.2m$89.1m$71.6m$63.7m$47.8m$66.8m$49.3m
Gross profit$50.4m$27.0m$70.6m$53.9m$47.5m$32.3m$52.7m$37.2m
Operating income−$11.0m−$22.1m$24.0m$14.7m$11.4m−$11.2m$12.6m$1.3m
Net income−$17.3m−$27.6m$6.6m$1.0m$5.0m−$17.8m$6.8m−$4.2m
Diluted earnings per share-0.46-0.740.180.030.14-0.480.19-0.12
Cash from operations−$9.0m−$8.0m$8.0m$16.0m—$19.0m−$17.0m$2.0m
Capital spending——————−$37.0m—
Free cash flow——————−$54.0m—
Total assets$416.8m$419.5m$399.5m$363.1m$345.0m$364.2m$389.0m$351.5m
Cash and short-term investments$83.9m$94.6m$72.9m$74.3m$55.8m$66.7m$47.2m$72.6m
Debt$944,000$293.0m$244.1m$243.7m$222.9m$221.4m$220.0m$186.6m
Shareholders' equity$15.2m$28.7m$52.4m$47.0m$49.7m$56.5m$69.7m$58.0m

Financial ratios

Data as of 4 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin75.1%75.3%69.6%71.3%74.9%70.4%
Operating margin8.2%4.5%0.6%-7.6%4.6%1.5%
Net margin-1.9%-8.8%-18.7%-15.9%-24.8%-6.9%
Return on equity-9.8%-25.1%-34.7%-52.4%-159.6%-12.3%
Return on assets-1.3%-4.5%-7.8%-9.0%-18.3%-5.8%
Free cash flow yield4.3%1.6%15.5%1.1%4.3%-0.0%
Revenue growth36.4%53.3%47.0%22.2%48.3%-4.5%
Earnings growth-70.6%-28.4%73.3%-21.8%436.4%-2098.2%
Current ratio2.20x2.08x2.82x6.35x6.24x3.79x
Debt to equity4.65x3.16x2.61x3.90x6.37x0.62x
Equity ratio13.1%17.9%22.6%17.1%11.5%47.3%
Interest coverage0.93x0.40x0.04x-0.93x0.62x0.33x
R&D as a share of sales4.7%6.1%5.1%3.4%15.3%4.9%
Buybacks as a share of market value-2.7%-1.3%-20.1%-7.1%-6.7%0.5%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue45.4%41.0%39.6%
Operating income172.0%151.3%—
Net income-28.5%8.9%-10.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin75.2%73.6%73.5%71.2%
Operating margin10.1%7.2%6.4%-0.2%
Net margin-4.8%-8.8%-10.2%-11.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-350.5-68.7-16.2-19.7-8.4-33.7—6.1-1.9-1.6
Price to sales6.66.03.03.12.12.32.52.10.81.5

Market value over time

30 Dec 2016 to 3 Nov 2026, in USD

$32.5m$1.07bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return31%238%32%41%63%-27%49%192%-1%-76%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 5-to-1 reverse split · 8 Feb 2013
  • 8-to-1 reverse split · 24 Feb 2012
  • 1-to-0.4625 reverse split · 21 Sept 2007

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.